Martin Dreyling

MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.

W. Hiddemann, S. Bohlander, C. Schoch, 1998, Blood.

Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients

R. Siebert, W. Hiddemann, S. Bohlander, 2000, Leukemia.

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of t

N. Schmitz, W. Hiddemann, M. Boccadoro, 2005, Blood.

Acute Leukemias

E. Estey, H. Kantarjian, M. Dreyling, 2021, Handbook of Pediatric Hematology and Oncology.